Can this be signed electronically?

Yes. Electronic signatures meet legal standards under the ESIGN Act (15 U.S.C. ch. 96) and state UETA laws so long as intent, consent, attribution, and retention are satisfied.

Do I need a BAA with my eSignature vendor?

If the form includes protected health information, a signed Business Associate Agreement is required to meet HIPAA obligations when a vendor stores or transmits PHI.

When is notarization required?

Most routine clinical disclosures do not require notarization, but state rules vary for certain legal declarations; check state notary and public-health guidance before assuming notarization is unnecessary.

What if patient cannot sign electronically?

Provide a paper alternative or capture a wet ink signature; for consumer-facing records ensure the consumer disclosure about electronic records and an opt-out mechanism per 15 U.S.C. §7001(c).

How long must the record be retained?

Follow HIPAA retention of 6 years from creation or last effective date (45 CFR §164.530(j)) and any longer state-specific periods applicable to clinical records.

Are simple e-signatures enough for labs?

Simple electronic signatures with robust audit trails are generally acceptable for administrative and clinical documentation; regulated submissions (e.g., FDA-bound records) may require 21 CFR Part 11–compliant signatures.

Electronic Signature
Templates
Healthcare
Healthcare Tick Disclosure

Healthcare Tick Disclosure

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE TICK DISCLOSURE

This Healthcare Tick Disclosure documents an encounter in which a tick exposure was identified, measures taken at the time of discovery, and authorization for any diagnostic testing, specimen submission, and release of results. Completion of this form provides clinical and public health documentation and records the patient's informed consent for testing and disclosure as described below.

Patient Information

Patient Name

Date of Birth

Gender

Address

Primary Phone

Email

Emergency Contact

Insurance / Billing

Insurance Provider

Policy Number

Group Number

Subscriber Name (if different)

Medical History

Current Medications Allergies Prior Surgeries / Significant Medical History Chronic Conditions

Tick Exposure Details

Date of exposure/encounter: Time (if known):

Location of Exposure

Tick found: Attached Detached (not attached)

Estimated Duration Tick Was Attached

Less than 24 hours Approximately 24–48 hours Greater than 48 hours Unknown

Tick Description (size, color, distinguishing marks) Removed By / Method of Removal

Specimen Submission & Diagnostic Testing

Tick submitted for testing: Yes No

If submitted, Specimen/Bag ID

Additional testing requested: PCR on tick Patient blood serology

Receiving Laboratory / Facility

Risks, Benefits, and Limitations

I understand that testing of ticks and serologic testing of blood may aid clinical decision-making but has inherent limitations. Negative results do not rule out future infection and positive results require clinical correlation. Test sensitivity and specificity vary by method and timing. There may be false positives and false negatives. Results may influence treatment recommendations including prophylactic antibiotics or further follow-up.

I understand that laboratory testing may take several days to weeks to return and that clinical decisions will be made based on presenting signs, symptoms, and clinician judgment irrespective of pending laboratory results.

I acknowledge that I received verbal explanation of risks, benefits, and limitations and have had an opportunity to ask questions answered to my satisfaction.

I understand that certain communicable disease results may be reportable to public health authorities as required by law.

Patient Acknowledgment I acknowledge that I understand the risks, benefits, and limitations described above.

Authorization & Release

I authorize the treating provider and the facility named below to submit the identified specimen(s) for diagnostic testing and to release test results to my treating clinicians, my insurance carrier (if required for billing), and public health authorities when required by law. I authorize the receiving laboratory to perform diagnostic testing as ordered and to release results to the treating provider and public health authorities as required.

Treating Clinician / Provider

This authorization is valid until: (If no date entered, authorization is valid for one year from signature date.)

I understand I may revoke this authorization in writing at any time, except to the extent that action has already been taken in reliance on it. Revocation will not affect disclosures already made in reliance on this authorization.

Patient Rights

Privacy & Reporting

Information generated by testing and this disclosure will be maintained in the patient's medical record and handled in accordance with applicable privacy laws. Certain infectious disease results may be reported to public health authorities without additional consent where required by law.

Acknowledgment of Privacy Notice I acknowledge that I have been informed of privacy practices and understand possible reporting obligations described above.

Provider Certification (for completion by staff)

Name of Staff Completing Form Facility / Clinic Date Form Completed

If signed by parent or guardian, indicate relationship:

Patient Printed Name:

Signature:

Date:

What the Healthcare Tick Disclosure Is and when it applies

The Healthcare Tick Disclosure is a standardized patient-facing disclosure used in clinical and public-health settings to record and communicate exposure or encounter details when a tick bite or tick-borne illness is suspected. It documents patient identification, exposure date and location, symptoms observed, clinician assessment, recommended testing or prophylaxis, and any data-sharing consents required for public-health reporting. The form supports clinical continuity, auditability, and appropriate follow-up while clarifying what information may be shared with local health authorities or labs.

Why a formal disclosure matters in patient safety and compliance

A clear Healthcare Tick Disclosure reduces clinical ambiguity, supports timely testing and prophylaxis decisions, and creates an auditable record for public-health reporting and reimbursement. It also documents patient consent for data uses that may be required under HIPAA or state public-health laws.

Who completes and reviews this disclosure

Typical users include clinicians, triage nurses, infectious disease specialists, and public-health staff who need a formal exposure record.

Clinic staff completing intake and exposure details for patient record and follow-up
Public-health officers using extracted fields for surveillance and case investigation
Laboratory or referral clinics receiving specimen and exposure context with test requests

The form clarifies responsibilities and creates a consistent handoff between clinical care, laboratory processing, and public-health reporting.

Core sections included in a professional Healthcare Tick Disclosure

A complete disclosure groups information into standard sections so reviewers can act quickly. Each section supports clinical decision-making, traceability, and any required legal notices.

Patient details

Full legal name, DOB, contact, and medical record number to ensure accurate identification and matching with lab results.

Exposure specifics

Date, time, and precise location of bite or exposure plus activity context (e.g., hiking, yard work).

Symptoms and timeline

Onset date, rash description, systemic symptoms, and progression to guide testing and treatment urgency.

Clinical actions

Prophylaxis given, tests ordered, treatment started, and scheduled follow-up or referrals.

Data sharing consent

Patient authorization for disclosure to labs, public-health agencies, or third-party care providers when required.

Administrative notes

Clinician name, signing authority, timestamps, and internal coding for billing or surveillance.

Step-by-step: completing the disclosure in a clinical visit

Follow these steps to collect exposure details and document clinician actions in one encounter.

01

Gather identifiers: Confirm full name, DOB, and contact information.
02

Record exposure: Log date, location, and circumstances of the exposure.
03

Assess symptoms: Document onset, rash, fever, and other relevant signs.
04

Document actions: Note testing ordered, prophylaxis given, and follow-up plans.

Workflow: from intake to reporting

This disclosure moves through defined points of care and reporting to ensure continuity and legal traceability.

Intake entry: Front-desk or nurse records initial exposure details.
Clinical review: Clinician documents assessment and orders.
Lab coordination: Specimen and context are transmitted to lab with identifiers.
Public-health report: Where required, essential fields are reported to local health authority.

Configuring an online workflow for this disclosure

Set up field validation, conditional routing, and access controls to reduce errors and preserve PHI.

Field	Configuration
Patient ID validation	Require MRN or exact DOB match
Conditional fields	Show treatment fields only if symptoms present
Audit logging	Enable full timestamp and IP capture
Access control	Limit export to authorized roles

Technical considerations for eSubmission and signing

Choose a platform that supports secure eSignatures, audit trails, and HIPAA-compliant handling when PHI is present.

Supported formats: PDF, DOCX
Authentication options: Email, SMS code, or stronger
Integrations: EHR, lab portals

Ensure the platform provides encryption in transit and at rest, a reliable audit trail, and a BAA if handling protected health information.

Essential security and compliance controls to require

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

Audit trail: Timestamps, IP, action log

Access control: Role-based permissions

HIPAA BAA: Business Associate Agreement required

Authentication: Email, SMS, or multi-factor

Retention controls: WORM or policy-based retention

Risks and potential consequences of incomplete or incorrect disclosures

Delayed care: Missed prophylaxis window

Billing denial: Insufficient documentation for reimbursement

Public-health lapses: Failure to report required cases

Privacy violations: HIPAA breach risk and penalties

Legal exposure: Liability for negligent records

Data mismatch: Lab result misattribution

Common mistakes to avoid

Incomplete location details that hinder exposure tracing
Using ambiguous symptom descriptions instead of objective findings
Failing to capture consent for lab or public-health disclosure
Mismatched patient identifiers across systems causing delays

Time-sensitive steps and typical processing expectations

Some actions tied to a tick exposure are time-sensitive; document dates and follow exact time windows for testing and prophylaxis.

Exposure documentation:

Document immediately at visit; same-day entry recommended

Prophylaxis window:

Start prophylaxis per clinical guidance within 72 hours of exposure

Lab submission:

Send specimens within 24–48 hours when timely testing matters

Public-health reporting:

Report within jurisdictional timeframe if case meets criteria

Record retention:

Retain per HIPAA and state rules; see retention timeline

Key milestones from encounter to follow-up

Track these stages to ensure timely clinical action and compliant reporting across systems.

01

Stage One: Intake

Record identifiers, exposure details, and consent immediately.

02

Stage Two: Clinical assessment

Assess symptoms and decide testing or prophylaxis.

03

Stage Three: Laboratory action

Collect and transmit specimens with complete context.

04

Stage Four: Reporting and follow-up

Notify public-health officials if required and schedule patient follow-up.

Representative eSignature pricing and feature comparison for healthcare disclosures

Compare baseline pricing and common features relevant to handling protected health information and high-volume disclosures. signNow is listed first per vendor table conventions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Practical examples of use in real-world workflows

Two concise examples illustrate how the disclosure supports clinical and public-health processes.

Clinic example

A primary-care clinic documents a tick encounter using the disclosure to record exposure and immediate doxycycline prophylaxis decision

The clinic includes exposure location and symptom onset
The structured record allowed rapid lab matching and scheduled a 10-day follow-up, reducing missed prophylaxis opportunities and simplifying billing documentation.

Public-health example

A county health department uses extracted fields for surveillance after a cluster of tick-bite reports

Location and date fields feed into case mapping
Standardized disclosures enabled timely case aggregation, targeted public messaging, and efficient lab routing for confirmatory testing.

Practical tips to improve accuracy and reduce downstream work

Adopt these practices to minimize errors, support compliance, and speed follow-up actions.

Use templates

Pre-filled clinical templates reduce omission and standardize required fields for surveillance and lab requests.

Validate IDs

Match DOB and MRN to the EHR at intake to avoid misattributed lab results.

Capture consent clearly

Record explicit data-sharing consent when PHI will be sent to public-health or third-party labs.

Enable audit logs

Maintain immutable audit trails for each signed disclosure to support clinical and compliance reviews.

Frequently asked questions about electronic disclosures and signatures

Answers to common operational and legal questions encountered when using electronic Healthcare Tick Disclosures.

Need help? Contact support

Can this be signed electronically?
Yes. Electronic signatures meet legal standards under the ESIGN Act (15 U.S.C. ch. 96) and state UETA laws so long as intent, consent, attribution, and retention are satisfied.
Do I need a BAA with my eSignature vendor?
If the form includes protected health information, a signed Business Associate Agreement is required to meet HIPAA obligations when a vendor stores or transmits PHI.
When is notarization required?
Most routine clinical disclosures do not require notarization, but state rules vary for certain legal declarations; check state notary and public-health guidance before assuming notarization is unnecessary.
What if patient cannot sign electronically?
Provide a paper alternative or capture a wet ink signature; for consumer-facing records ensure the consumer disclosure about electronic records and an opt-out mechanism per 15 U.S.C. §7001(c).
How long must the record be retained?
Follow HIPAA retention of 6 years from creation or last effective date (45 CFR §164.530(j)) and any longer state-specific periods applicable to clinical records.
Are simple e-signatures enough for labs?
Simple electronic signatures with robust audit trails are generally acceptable for administrative and clinical documentation; regulated submissions (e.g., FDA-bound records) may require 21 CFR Part 11–compliant signatures.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now